Menu
NuVision Biotherapies
NuVision has developed a unique way to process and preserve amnion which can be applied to the surface of the eye to promote healing of ‘front of eye’ disease and trauma.
Biotherapy
School of Medicine
Profile
Prior to NuVision, cryopreserved amnion had to be stored in specialist facilities. Delivery of the amnion had to be within thawing time before surgery which is a constraint for the NHS and meant the treatment could only be used for scheduled surgery.
NuVision’s first product, Omnigen® is a dry, sterile disc that does not require specialist storage conditions.
Omnigen® has further potential for use in human and veterinary treatments for conditions that feature chronic pain or inflammation, and flexible storage conditions potentially make it suitable for remote emergency treatment by military surgeons.
@NuVisBio on Twitter
Last chance to register for tonight’s webinar. Join our speakers for three excellent case studies and the opportunity to ask your questions on using amniotic membranes in ophthalmology.
Register here: https://bit.ly/3lIffyH
3 days to go! Don’t miss this clinical webinar on using an amniotic membrane to manage a range of ocular conditions. Not to be missed by ophthalmologists looking to tackle long waiting lists. Have you registered yet?
One week until our clinical webinar on “innovations in amniotic membrane application in the management ocular surface disease”. To register, please visit this link: https://bit.ly/3GawCk4
Persistent epithelial defects are ocular indications that are present in ophthalmology departments. According to a publication by Maqsood et al patients had a 86% complete or partial heal rate when treated with Omnigen and OmniLenz. Read more here: https://bit.ly/376WyN5
Neoplasms are growths that can occur on any part of the eye. They can either be benign or malignant, but over 800 people in the UK are diagnosed with eye cancer every year. Amnion can be used to aid in the healing of the ocular surface following tumour excision.
In 2020-21, ophthalmology had 5.4 million outpatient appointments. It’s vital that patients are moved through the care pathway quickly when dealing with such high numbers. That is why having treatments like amnion available at an ambulatory level is so important.
Allen et al have showed the sustained release of important biochemistry including epidermal growth factor (EGF) is more sustained in specially treated dehydrated amniotic membrane (AM) than cryopreserved AM over a 10-day period.
Source: https://pubmed.ncbi.nlm.nih.gov/24205233/
This patient was at risk of the removal of their eye and orbital contents. However, an autolimbal transplant was performed using donor limbus from the other eye and the ACER technique with Omnigen.
https://bit.ly/3zNXvX0
